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Abstract
Background: Food allergy is a serious health concern among infants and young children. Although immunological
mechanism of food allergy is well documented, the molecular mechanism(s) involved in food allergen sensitization
have not been well characterized. Therefore, the present study analyzed the mesenteric lymph node (MLN)
transcriptome profiles of BALB/c mice in response to three common food allergens.
Results: Microarray analysis identified a total of 1361, 533 and 488 differentially expressed genes in response to
b-lactoglobulin (BLG) from cow’s milk, ovalbumin (OVA) from hen’s egg white and peanut agglutinin (PNA)
sensitizations, respectively (p < 0.05). A total of 150 genes were commonly expressed in all antigen sensitized
groups. The expression of seven representative genes from microarray experiment was validated by real-time RT-
PCR. All allergens induced significant ear swelling and serum IgG1 concentrations, whereas IgE concentrations were
increased in BLG- and PNA-treated mice (p < 0.05). Treatment with OVA and PNA significantly induced plasma
histamine concentrations (p < 0.05). The PCA demonstrated the presence of allergen-specific IgE in the serum of
previously sensitized and challenged mice.
Conclusions: Immunological profiles indicate that the allergen dosages used are sufficient to sensitize the BALB/c
mice and to conduct transcriptome profiling. Microarray studies identified several differentially expressed genes in
the sensitization phase of the food allergy. These findings will help to better understand the underlying molecular
mechanism(s) of food allergen sensitizations and may be useful in identifying the potential biomarkers of food
allergy.
Background
Food allergy is serious health concern, affecting approxi-
mately 1-2% adults and 6-8% children [1]. Allergies to
egg white and cow’s milk are most common among
children, whereas the most severe form of the food
allergy is induced by peanuts [2]. Food allergy is typi-
cally considered an IgE-mediated type I hypersensitivity
reaction [3]. Although increased production of IgE and
Th2 cytokines (IL-4, IL-5 and IL-13) are considered
common markers of food allergy [4], absence of IgE or
increased levels of Th1 cytokines (IL-2, IFN-g and TNF-
a) have also been observed in several instances of food
a l l e r g y[ 5 , 6 ] ,m a i n l yi nr e s p o n s et oc o w ’sm i l k[ 7 , 8 ] .
Several animal studies have demonstrated that the invol-
vement of the Th2 signaling pathway is too simplistic to
explain the mechanism(s) of food allergies, since com-
bined involvement of Th1 and Th2 signaling pathways
have also been demonstrated [6,9]. Such uncertainty
over the Th1/Th2 paradigm emphasizes the need for
further research to unravel the molecular mechanism(s)
of food allergy.
Although a genetic basis for IgE-mediated conditions
such as asthma has been well documented, [10,11], little
is known about the specific genes involved in the patho-
genesis of food allergy. A study by de Jonge et al. inves-
tigated the mesenteric lymph node (MLN) gene
expression profiles of Brown-Norway (BN) rats that
were challenged with peanut extract, and they identified
64 differentially expressed genes [12]; the MLNs were
ideal tissue for studying the mechanisms of food allergy
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e n v i r o n m e n tt h a ti sc o n d u c i v eto efficient antigen trap-
ping and presentation to T-cells, the activation and pro-
liferation of antigen-specific lymphocytes, and memory
cell development [13,14]. In another study Cardoso
et al. reported significant up-regulation of the Gata-3,
IL-4, TNF-a, and IL-13 genes in the intestine of C57BL/
6 mice sensitized with peanut extract and challenged
with peanut seeds [15]. Although these differentially
expressed genes may be potential risk factor candidates
for peanut allergy, the induction of these genes may not
necessarily be involved in the immune response to other
food allergens. Recent studies indicate that Foxp3+ T
regulatory cells may play a protective role in food
allergy, and Foxp3 is considered an immunophenotype
marker of T regulatory cells. In a recent report Kro-
gulska et al. [16] suggested a possible protective role of
Foxp3 and IL-10 in food allergy, where the expression
of these genes was up-regulated in children who were
developing tolerance to allergenic foods. Another recent
report however, contradict to such tolerogenic effects of
Foxp3 in food allergy, where Foxp3 along with Nfat-C2,
IL-16 and Gata-3 genes were reported to up-regulated
in children with persisting cow’s milk allergy [17]. Such
conflicting reports make it difficult to identify reliable
biomarkers of food allergy. Therefore, it is necessary to
continue further research to identify other biomarkers
of food allergy.
A number of different animal models have been used
to study food allergy [18-21]. Mice, however, are the
most widely used model, and this is in part because
immunological and molecular tools and reagents for this
species are readily available. Also, their short breeding
cycle and smaller size make them a cost effective model
for conducting allergy research [22]. Of the different
murine strains that are available, the BALB/c strain has
been typically preferred over other strains because of its
high IgE response that is characteristic of an atopic phe-
notype [20].
A suitable route of exposure is critical for studying the
allergenicity of food proteins. Sensitization by intra-
gastric (i.g.) gavage has been used by several groups
[23,24], although there is a potential risk of developing
oral tolerance via this route [25]. Adjuvants, such as
cholera toxin, have also been used during oral sensitiza-
tion, however, eliciting an immune response via this
approach may not necessarily mimic the allergic
response in humans [26], and may lead to misinterpreta-
tion of the data due to hyperstimulation of the immune
system [27]. In order to avoid the development of toler-
ance and use of adjuvants, systemic exposure by intra-
peritoneal (i.p.) injection has been used by many groups,
and this has been reported to be reliable and effective
method for inducing sensitization [20,22].
In the following study, the transcriptome profile of
MLN from BALB/c mice was assessed using cDNA
microarrays to identify genes that are differentially
expressed in response to i.p. sensitization with three
common food allergens of varying potency; cow’s milk
b-lactoglobulin (BLG) < hen’s egg ovalbumin (OVA) <
peanut agglutinin (PNA) [20,28-30]. The sensitization
concentrations of the antigens used in this study were
shown to be sufficient to elicit type I allergic reactions
during a subsequent challenge. The results presented
here in this study may help to establish a method in
future to identify the potential allergenicity of other
food proteins. To the best of our knowledge, this study
is the first to analyze the MLN transcriptome profile of
BALB/c mice in response to BLG, OVA and PNA
sensitization.
Results
Differential gene expression profiling by cDNA microarray
analysis
Analysis of the differentially expressed genes was carried
o u to nt h eM L No fB A L B / cm i c es e n s i t i z e dw i t hc o m -
mon food antigens of varying allergenic potencies.
These MLNs were collected 24 h after the second sensi-
tization. Analysis of BLG sensitized mice revealed 1361
differentially expressed genes with 1030 up-regulated
and 331 down-regulated (p < 0.05). A total of 533 genes
were differentially expressed in the OVA sensitized
group (p < 0.05); 256 genes were up-regulated and 277
genes were down-regulated. Finally, in PNA sensitized
animals, 488 genes were differentially expressed (p <
0.05); 207 genes being up-regulated and 281 genes being
down-regulated. The number of common and uniquely
expressed genes for each antigen sensitization is indi-
cated in Figure 1(a). A complete list of genes that were
Figure 1 Common and unique differentially expressed genes,
and gene ontology biological processes. (a) Genes significantly
differentially expressed (p ≤ 0.05) in response to BLG, OVA or PNA
sensitization. A total of 150 overlapping genes were commonly
expressed among all of the antigen sensitized groups. (b) Gene
ontology (GO) biological processes significantly (p ≤ 0.05) enriched
with the genes from BLG OVA and PNA sensitized groups. A total of
46 overlapping biological processes were commonly enriched
among all 3 allergen sensitized groups.
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PNA sensitization is provided in Additional file 1. A
total of 150 genes were commonly expressed in all of
t h eB L G ,O V A ,a n dP N As e n s i t i z e dg r o u p s( F i g u r e1 a ;
Additional file 2). Top 20 of these common differentially
expressed genes are summarized in Table 1. As
expected, sensitization with PBS did not have any signif-
icant effect on MLN gene expression.
Gene ontology (GO) analysis
Genes that were significantly differentially expressed in
response to antigen sensitization were further analyzed
to understand their biological relevance and molecular
functions. A total of 204 GO biological processes were
identified as significantly enriched with the genes from
BLG sensitized group (p < 0.05) (Figure 1b; Additional
file 3). From these 204 biological processes, approxi-
mately 70 processes were directly related with immune
or inflammatory response. Some of these immune
response related biological processes with high percent
( % )e n r i c h m e n ti n c l u d e sBc e ll receptor signaling path-
way [GO:0050853], regulation of immunoglobulin
mediated immune response [GO:0002889], antigen pro-
cessing and presentation of peptide antigen via MHC
class II [GO:0002495] and regulation of phagocytosis
[GO:0050764] (Figure 2a). Genes differentially expressed
in response to OVA sensitization enriched 327 GO bio-
logical processes (p < 0.05) (Figure 1b; Additional file 4),
of which at least 71 processes were related with immune
or hypersensitivity response. Some of these immune or
hypersensitivity related processes high percent (%)
enrichment includes mast cell homeostasis [GO:00
33023], Fc receptor mediated stimulatory signaling path-
way [GO:0002431], eosinophil activation [GO:0043307],
complement activation, alternative pathway [GO:00
06957], regulation of B cell mediated immunity
[GO:0002712] and hypersensitivity [GO:0002524] (Fig-
ure 2b). Finally, GO analysis with the genes differentially
expressed in response to PNA sensitization enriched
295 biological processes (p < 0.05) (Figure 1b; Addi-
tional file 5). Among these 295 biological processes,
approximately 73 processes were immune or hypersensi-
tivity related including regulation of interleukin-4 pro-
duction [GO:0032673], mast cell homeostasis [GO:00
33023], regulation of vasoconstriction [GO:0019229],
regulation of B cell mediated immunity [GO:0002712],
regulation of acute inflammatory response [GO:00
02673] and hypersensitivity [GO:0002524] (Figure 2c).
Comparison of the GO biological processes among aller-
gen sensitized groups revealed a total of 46 overlapping
biological processes commonly enriched (p < 0.05)
in response to BLG, OVA and PNA sensitizations
Table 1 List of common top 10 up-regulated and top 10 down-regulated genes significantly (p < 0.05) differentially
expressed in BALB/c mice in response to BLG, OVA and PNA sensitizations
BLG OVA PNA
Unigene ID Gene Symbol Gene Name Fold Change P-Value Fold Change P-Value Fold Change P-Value
Mm.8245 Timp1 Tissue inhibitor of metalloproteinase 1 9.8 4E-03 18.4 2E-03 13.4 1E-02
Mm.259609 Prrg4 Proline rich Gla (G-carboxyglutamic acid) 4 3.5 3E-04 7.6 8E-03 4.7 1E-02
Mm.289645 Meg3 Maternally expressed 3 4.7 1E-03 4.2 1E-02 8.3 1E-02
Mm.646 Tpm2 Tropomyosin 2, beta 3.8 4E-05 2.6 4E-04 2.9 3E-04
Mm.295533 Flna Filamin, alpha 3.2 3E-05 2.6 2E-04 2.4 8E-04
Mm.22701 Gas1 Growth arrest specific 1 3.2 2E-04 2.6 3E-04 2.1 7E-03
Mm.26700 Tmem16a Transmembrane protein 16A 5.3 4E-03 2.5 3E-04 3.5 4E-03
Mm.12459 Ankrd10 Ankyrin repeat domain 10 3.5 4E-03 2.2 3E-03 2.6 7E-03
Mm.196110 Hba-a1 Hemoglobin alpha, adult chain 1 3.6 2E-03 2.2 5E-03 2.8 4E-03
Mm.20954 Rgs5 Regulator of G-protein signalling 5 2.8 9E-06 2.2 2E-04 2.5 2E-03
Mm.431947 Ovgp1 Oviductal glycoprotein 1 -4.4 4E-05 -4.6 1E-03 -3.0 2E-03
Mm.33401 Mgam Maltase-glucoamylase -5.5 6E-08 -4.6 2E-08 -9.2 6E-06
Mm.1641 Car4 Carbonic anhydrase 4 -3.6 1E-04 -4.7 6E-04 -8.0 7E-06
Mm.4533 Apoa4 Apolipoprotein A-IV -11.2 5E-06 -5.3 2E-08 -19.1 8E-06
Mm.1186 Car2 Carbonic anhydrase 2 -1.5 1E-02 -6.0 2E-03 -5.2 7E-06
Mm.210336 Lgals4 Lectin, galactose binding, soluble 4 -11.2 8E-07 -7.2 2E-05 -5.0 3E-05
Mm.7244 Agr2 Anterior gradient 2 -5.5 3E-10 -9.7 9E-07 -13.9 7E-07
Mm.297976 Gpc1 Glypican 1 -4.9 7E-08 -10.7 3E-12 -7.3 1E-05
Mm.273195 Car1 Carbonic anhydrase 1 -5.4 8E-08 -12.6 2E-10 -8.2 9E-06
Mm.11869 AI427122 Expressed sequence AI427122 -8.3 4E-07 -13.2 2E-08 -8.5 2E-06
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48% of these common processes (22 processes)
were related to immune or hypersensitivity responses
(Table 2). Two common differentially expressed genes,
Fc receptor, IgE, high affinity I, gamma polypeptide
(FcεR1g)a n dC o m p l e m e n tc o m p o n e n t3( C 3 )p l a y e da
central role for the enrichment of the majority of these
hypersensitivity or immune responsive biological pro-
cesses (Table 3). Other genes that were involved in the
enrichment of these common GO biological processes
include Immunoglobulin joining chain (Igj), Keratin 8
(Krt8), Scinderin (Scin), Signal transducer and activator
of transcription 3 (Stat3), Supervillin (Svil) and Villin 1
(Vil1) (Table 3).
GO analysis also revealed the molecular functions of the
differentially expressed genes. A total of seven GO
molecular functions were commonly enriched with the
genes from BLG, OVA and PNA sensitized groups
(Table 4). Among these molecular functions calcium ion
binding [GO:0005509] enriched with the highest num-
ber of genes from either BLG, OVA or PNA sensitized
groups. Actin binding [GO:0003779] is another signifi-
cant commonly enriched molecular function; similar
actin filament related processes were also observed to
be enriched in GO biological process category (Table 2).
Validation of the differentially expressed genes by real-
time RT-PCR
Differential expression of 7 representative genes from
the microarray experiment was validated by real-time
RT-PCR. These seven genes were selected based on
their previous known relation with allergy, fold change,
Figure 2 Immune or hypersensitivity related GO biological processes significantly (p < 0.05) enriched with the genes from (a) BLG, (b)
OVA and (c) PNA sensitized group with high percent (%) enrichment. Numbers within the parenthesis indicate the percent enrichment of
each GO biological process.
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lipid transfer domain containing 4), Igj (Immunoglobu-
lin joining chain), Timp1 (Tissue inhibitor of metallo-
proteinase 1), Cd79a (CD79A antigen), Itgb1 (Integrin
beta 1 or fibronectin receptor beta), Pex13 (Peroxisomal
biogenesis factor 13) and Syt4 (Synaptotagmin IV)
(Table 5). The corresponding real-time RT-PCR and
microarray fold changes in gene expression were highly
correlated for all of the seven validated genes (Figure 3),
as indicated by Spearman’s rank correlation rho value of
0.923 (p < 0.001).
Topical ear challenges
The ear swelling response was measured in BALB/c mice
to assess the type I hypersensitivity response induced by
the food allergens. All mice that were sensitized and chal-
lenged with 2% BLG, 2% OVA or 0.2% PNA responded
significantly with an ear swelling response when com-
pared to mice that received only PBS, or were challenged
only with antigen (p < 0.001). Linear and quadratic con-
trasts revealed that the ear swelling among mice that
were sensitized and challenged with BLG, OVA and PNA
antigens increased significantly at all time points (p <
0.001). The peak ear swelling was recorded at 1 h post
challenge and the response was gradually deceased over
time (Figure 4). Figure 4 indicates ear swelling response
only at 0.5, 1 and 2 h post-challenge. The ear swelling
responses were not significantly different among antigen
treatments (Additional file 7).
Total serum IgG1 and IgE response to sensitization and
topical challenge
Immunogenicity and allergenicity of each antigen was
evaluated by measuring changes in total serum IgG1
and IgE concentrations respectively 24 h post challenge.
Total IgG1 concentrations in mice that were sensitized
and challenged with BLG, OVA or PNA increased when
compared to mice that received PBS alone, or were
Table 2 Gene ontology (GO) biological processes related with immune, inflammatory or hypersensitivity responses
commonly enriched with the genes differentially expressed in BALB/c mice in response to BLG, OVA and PNA
sensitizations
BLG Sensitized OVA Sensitized PNA Sensitized
GO Biological Processes GO
ID
Genes Fisher’s Exact
P-Value
Genes Fisher’s Exact
P-Value
Genes Fisher’s
Exact
P-Value
Response to stimulus 50896 100 0.005 50 0.011 50 0.002
Actin filament-based process 30029 22 0.011 11 0.041 12 0.009
Cytokine and chemokine mediated signaling pathway 19221 10 0.000 4 0.038 5 0.006
Acute inflammatory response 2526 9 0.001 6 0.001 5 0.004
Humoral immune response 6959 8 0.001 6 0.001 5 0.002
Regulation of actin filament depolymerization 30834 6 0.011 4 0.012 5 0.001
Actin filament depolymerization 30042 6 0.011 4 0.012 5 0.001
Humoral immune response mediated by circulating
immunoglobulin
2455 6 0.001 3 0.024 3 0.019
Negative regulation of actin filament depolymerization 30835 5 0.028 4 0.008 5 0.001
Phagocytosis 6909 5 0.043 4 0.012 3 0.049
Positive regulation of defense response 31349 4 0.044 4 0.003 3 0.019
Positive regulation of endocytosis 45807 4 0.025 3 0.016 3 0.012
Positive regulation of response to external stimulus 32103 4 0.034 3 0.020 3 0.015
Positive regulation of inflammatory response 50729 3 0.038 3 0.005 3 0.004
Myeloid leukocyte mediated immunity 2444 3 0.026 3 0.003 2 0.032
Positive regulation of phagocytosis 50766 3 0.026 2 0.038 2 0.032
Regulation of phagocytosis 50764 3 0.026 2 0.038 2 0.032
Positive regulation of immunoglobulin mediated
immune response
2891 3 0.009 2 0.019 2 0.016
Regulation of immunoglobulin mediated immune response 2889 3 0.009 2 0.019 2 0.016
Positive regulation of inflammatory response
to antigenic stimulus
2863 3 0.016 2 0.028 2 0.023
Positive regulation of B cell mediated immunity 2714 3 0.009 2 0.019 2 0.016
Regulation of B cell mediated immunity 2712 3 0.009 2 0.019 2 0.016
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IgE concentrations in the serum were also significantly
increased in animals that had been sensitized and chal-
lenged with BLG and PNA when compared to mice that
received only PBS or were challenged with antigen,
alone (p < 0.05; Figure 6). Concentrations of IgE in the
OVA treated mice were also increased, but statistical
significance was not achieved after Bonferroni’s correc-
tion (p = 0.06). IgG1 and IgE concentrations were not
significantly different among antigen treatments.
Table 3 Some significant genes involved in the enrichment of the common GO biological processes related to immune
or hypersensitivity
Gene Ontology Biological Process
UniGene
ID
Gene
Symbol
BLG Sensitized Group OVA Sensitized Group PNA Sensitized Group
Mm.19131 C3 Acute inflammatory response
[GO:0002526]; Humoral immune
response [GO:0006959]; Phagocytosis
[GO:0006909]; Positive regulation of
response to external stimulus
[GO:0032103]; Regulation of B cell
mediated immunity [GO:0002712];
Positive regulation of defense response
[GO:0031349]
Acute inflammatory response
[GO:0002526]; Humoral immune
response [GO:0006959]; Phagocytosis
[GO:0006909]; Positive regulation of
response to external stimulus
[GO:0032103]; Regulation of B cell
mediated immunity [GO:0002712];
Positive regulation of defense response
[GO:0031349]
Acute inflammatory response
[GO:0002526]; Humoral immune
response [GO:0006959]; Phagocytosis
[GO:0006909]; Positive regulation of
response to external stimulus
[GO:0032103]; Regulation of B cell
mediated immunity [GO:0002712];
Positive regulation of defense response
[GO:0031349]
Mm.22673 Fcer1g Acute inflammatory response
[GO:0002526]; Phagocytosis
[GO:0006909]; Positive regulation of
response to external stimulus
[GO:0032103]; Regulation of B cell
mediated immunity [GO:0002712];
Positive regulation of defense response
[GO:0031349]
Acute inflammatory response
[GO:0002526]; Phagocytosis
[GO:0006909]; Positive regulation of
response to external stimulus
[GO:0032103]; Regulation of B cell
mediated immunity [GO:0002712];
Positive regulation of defense response
[GO:0031349]
Acute inflammatory response
[GO:0002526]; Phagocytosis
[GO:0006909]; Positive regulation of
response to external stimulus
[GO:0032103]; Regulation of B cell
mediated immunity [GO:0002712];
Positive regulation of defense response
[GO:0031349]
Mm.342177 Igh-6 Humoral immune response
[GO:0006959]
Humoral immune response
[GO:0006959]
Humoral immune response
[GO:0006959]
Mm.1192 Igj Humoral immune response
[GO:0006959]
Humoral immune response
[GO:0006959]
Humoral immune response
[GO:0006959]
Mm.358618 Krt8 Cytokine and chemokine mediated
signaling pathway [GO:0019221]
Cytokine and chemokine mediated
signaling pathway [GO:0019221]
Cytokine and chemokine mediated
signaling pathway [GO:0019221]
Mm.2416 Scin Regulation of actin filament
depolymerization [GO:0030834]
Regulation of actin filament
depolymerization [GO:0030834]
Regulation of actin filament
depolymerization [GO:0030834]
Mm.249934 Stat3 Cytokine and chemokine mediated
signaling pathway [GO:0019221]; Acute
inflammatory response [GO:0002526]
Acute inflammatory response
[GO:0002526]; Cytokine and chemokine
mediated signaling pathway
[GO:0019221]
Cytokine and chemokine mediated
signaling pathway [GO:0019221]; Acute
inflammatory response [GO:0002526]
Mm.136791 Svil Regulation of actin filament
depolymerization [GO:0030834]
Regulation of actin filament
depolymerization [GO:0030834]
Regulation of actin filament
depolymerization [GO:0030834]
Mm.471601 Vil1 Regulation of actin filament
depolymerization [GO:0030834]
Regulation of actin filament
depolymerization [GO:0030834]
Regulation of actin filament
depolymerization [GO:0030834]
Table 4 Common GO molecular functions enriched with the genes differentially expressed in BALB/c mice in response
to BLG, OVA and PNA sensitizations
BLG Sensitized OVA Sensitized PNA Sensitized
GO Molecular Functions GO ID Genes Fisher’s Exact
P-Value
Genes Fisher’s Exact
P-Value
Genes Fisher’s Exact
P-Value
Calcium ion binding 5509 58 0.0003 34 0.0001 36 <0.0001
Cytoskeletal protein binding 8092 39 0.002 22 0.0019 23 0.0002
Actin binding 3779 30 0.0024 18 0.0012 20 <0.0001
Oxidoreductase activity, acting on CH-OH group
of donors
16614 14 0.0074 17 <0.0001 9 0.0022
Structural constituent of cytoskeleton 5200 11 0.0005 6 0.0055 9 <0.0001
Antigen binding 3823 3 0.0085 3 0.0009 3 0.0007
Structural constituent of muscle 8307 3 0.0037 2 0.0119 2 0.0099
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and i.p. challenged mice
Plasma histamine concentrations were measured as an
indicator of mast cell degranulation in BALB/c mice
that had been sensitized and challenged with BLG, OVA
or PNA. Elevated plasma histamine concentrations were
observed in OVA and PNA sensitized and challenged
mice, when compared to mice that received only PBS
(p < 0.01; Table 6). Histamine concentrations were also
increased in mice from the BLG treatment, however,
this did not reach statistical significance (p = 0.06).
Histamine concentrations among antigen treatment
groups were significantly different (p < 0.01).
Passive cutaneous anaphylaxis (PCA) reaction
A PCA assay was carried out to evaluate the antigen-
specific IgE response in BALB/c mice that had been sen-
sitized and challenged with BLG, OVA or PNA. Results
from PCA assay indicated that antigen-specific serum
from previously exposed mice was sufficient to elicit a
type I hypersensitivity response in naïve mice (p < 0.05).
Seventy five percent of mice that received BLG or
OVA-specific anti-serum had a positive PCA response,
whereas 100% mice that received PNA specific anti-
serum had a positive PCA response (Table 7). As
expected, none of the mice in any of the control groups
had any positive PCA reaction.
Table 5 Representative genes from microarray experiment validated by real-time RT-PCR with their corresponding
fold changes and p-values.
Microarray Experiment Real Time RT-PCR Experiment
Gene
Symbol
BLG Sensitization OVA Sensitization PNA Sensitization BLG Sensitization OVA Sensitization PNA Sensitization
Fold
Change
P-Value Fold
Change
P-Value Fold
Change
P-Value Fold
Change
P-Value Fold
Change
P-Value Fold
Change
P-Value
Stard4 -2.9 6E-04 -3.3 2E-03 -2.8 2E-04 -2.7 1E-03 -3.6 1E-03 -3.0 1E-03
Igj -1.8 8E-05 -2.0 1E-06 -1.7 7E-05 -2.7 2E-02 -3.1 2E-02 -2.0 4E-02
Timp1 9.8 4E-03 18.4 2E-03 13.4 1E-02 13.6 1E-02 9.4 3E-03 8.1 3E-02
Cd79a -3.7 5E-03 ---- -6.3 4E-04 ----
Itgb1 2.6 7E-03 ---- 2 . 3 4E-02 ----
Pex13 - - -2.0 5E-03 - - - - -1.8 3E-02 - -
Syt4 - - 7.0 8E-03 - - - - 4.4 3E-02 - -
Figure 3 Correlation of the corresponding fold changes of the
validated genes from microarray and real-time RT-PCR
experiments. Genes validated from BLG sensitized group are
Stard4, Igj, Timp1, Cd79a and Itgb1, and indicated with a “red
diamond”. Genes validated from OVA sensitized group are Stard4,
Igj, Timp1, Pex13 and Syt4 and indicated with a “black triangle”.
Genes validated from PNA sensitized group are Stard4, Igj and
Timp1, and indicated with a “green circle”. Genes Stard4, Igj and
Timp1 were commonly expressed in response to all three antigen
sensitizations. Genes Cd79a and Itgb1 were only expressed in BLG
sensitized mice, and genes Pex13 and Syt4 were expressed only in
OVA sensitized mice.
Figure 4 Ear swelling response in BALB/c mice.P e r c e n t( % )e a r
swelling was measured over time in BALB/c mice in response to
BLG (n = 8), OVA (n = 8) or PNA (n = 8) sensitization and challenge
(SC). Mice in the BLG, OVA and PNA SC groups indicated a
significant ear swelling response when compared to that in PBS SC
mice (n = 8) or mice in the BLG (n = 4), OVA (n = 4), PNA (n = 4)
and PBS (n = 4) challenge (C) only groups. Results expressed as LSM
± standard error of the mean (SEM). *** represents p < 0.001.
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In this study, BALB/c mice were used as a model of
food allergy in order to analyze the MLN transcriptome
profiles to explore the molecular mechanism(s) asso-
ciated with sensitization to three of the most common
food allergens; BLG, OVA and PNA. Analysis of ear
swelling, plasma histamine, total IgG1 and IgE concen-
trations, and antigen-specific IgE level (PCA) indicated
that BALB/c mice developed a type I allergic response
to these food allergens. These immunological profiles
also indicate that the initial exposure doses without any
adjuvants were sufficient to induce allergen sensitization
in BALB/c mice.
Although the ear swelling response is typically used to
assess contact allergy (type IV hypersensitivity) [31],
tape-stripping prior to topical antigenic challenge
enabled us to use this endpoint to measure a type I
hypersensitivity response. Massive ear swelling was
observed as early as 30 min post challenge and peaked 1
h post challenge. Such rapid swelling is characteristic of
IgE-mediated mast cell degranulation, a hallmark of a
type I allergic response [32]. The ear swelling test also
proved to be sensitive and was able to differentiate the
potencies of the antigens that used in this study. For
example, the ear swelling data demonstrated that PNA
was more potent than BLG and OVA for eliciting a type
I allergic response. The concentration of PNA solution
(0.2%) that used in this study was 10 times less than the
concentrations used for BLG and OVA solution (2%),
yet the magnitude of ear swelling observed in PNA sen-
sitized and challenged mice was not significantly differ-
ent to that observed in BLG or OVA sensitized and
challenged mice (Additional file 7). These results
demonstrate that this method is capable of differentiat-
ing the antigen potency and also able to generate reli-
able quantitative data for assessing the magnitude a type
I allergic response.
IgE antibodies are known to play a central role in med-
iating type I hypersensitivity reactions. In our study,
increased production of IgE in BALB/c mice sensitized
and challenged with BLG, OVA or PNA illustrates that
these mice experienced a IgE mediated type I allergic
reaction. In order to confirm that BALB/c mice used in
this study had an IgE mediated type I allergic response
and anaphylaxis, plasma histamine concentrations were
measured. In this study, rapid release of histamine within
20 min of the i.p. challenge confirmed the induction of
type I allergic response and subsequent degranulation of
mast cells. Traditionally, it was believed that food allergy-
related systemic anaphylaxis was only due to the interac-
tion between IgE and FcεRI on the mast cell surface, and
this lead to mast cell degranulation and the subsequent
release of histamines and other enzymes [33]. Reports,
however, suggest that an alternate pathway exists that is
dependent on the interaction of IgG1 and FcgRIII [34].
Mouse FcgRIII is a low affinity receptor, present on the
surface of the macrophages, neutrophils and natural killer
cells that binds to IgG1. Binding of soluble IgG1 with
blood-borne antigens must occur before they bind to
macrophage FcgRIII. In contrast to the IgE-mediated
pathway, this pathway takes relatively longer to induce
anaphylaxis, requires high concentrations of IgG1 for eli-
citation, and involves platelet activating factors (PAF),
rather than histamine, as the primary mediator in this
type of anaphylactic shock [34,35]. In our study, the
release of histamine within 20 min of i.p. challenge of
BALB/c mice strongly suggests that allergic and anaphy-
lactic responses related to BLG, OVA or PNA sensitiza-
tion and challenge were IgE mediated.
Finally, the PCA data in this study demonstrated that
BALB/c mice responded positively and developed BLG-,
OVA- or PNA-specific immunoglobulin IgE. This posi-
tive PCA response was exclusively due to the binding of
antigen-specific IgEs with FcεRIs on mast cell rather
Figure 5 Serum total IgG1 concentrations in BALB/c mice 24 h
post challenge. Results are expressed as LSM ± SEM. Multiple
comparisons among the treatments within groups were performed
using Bonferroni’s correction to adjust the p-values for the type-1
error rate. * p < 0.02; ** p < 0.01; *** p < 0.002
Figure 6 Serum total IgE concentrations in BALB/c mice 24 h
post challenge. Results are expressed as LSM ± SEM. Multiple
comparisons among the treatments within groups were performed
using Bonferroni’s correction to adjust the p-values for the type-1
error rate. * p < 0.06; ** p < 0.05; *** p < 0.01
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sensitized with antigen specific anti-sera and challenged
with the respective antigens and Evans blue dye after 48
h of anti-sera sensitization; only IgE is capable of remain
bound to high affinity FcεRI for this period of time [22].
Analysis of MLN transcriptome profile of BALB/c
mice sensitized with BLG, OVA or PNA revealed the
differential expression of numerous genes that are asso-
ciated with activation of the Th2 response. This method
of transcriptome profiling appeared to be very sensitive
that identified differential expression of hundreds of
genes in BALB/c mice within 24 h of the second sensiti-
zation with the given food allergens. Comparison of the
differentially expressed genes in BLG, OVA and PNA
sensitized groups implicates that a common set of genes
involved in the sensitization phase of the immune
response to these three food allergens in BALB/c mice.
A total of 150 overlapping genes being differentially
expressed in the same direction among the three food
allergen sensitized groups. Among these genes, the
expression of Timp1 was up-regulated, whereas the
expression of Stard4 and Igj were down-regulated in all
three antigen sensitized groups. The involvement of
Timp1 with the allergic response is very well documen-
ted; being an inhibitor of matrix metalloproteinases, it
plays a central role in degradation of extracellular
matrix and remodeling of tissue during inflammatory
process [36], and appears to be involved in asthma
[37,38]. Induction of Timp1 has also been implicated in
the pathogenesis of other allergic conditions including
atopic dermatitis, allergic contact dermatitis and chronic
obstructive pulmonary disease (COPD) [36,39,40].
S t a r d 4i sk n o w nt ob ei n v o l v e di nt h eb i n d i n ga n d
directional transport of the cholesterol into the liver for
the synthesis of bile acid [41], and its expression is
reported to be down-regulated in the presence of cho-
lesterol [42]. It is not clear from available reports
whether Stard4 plays any direct role in the allergic
response, however, the microarray and real-time RT-
PCR data from all antigen sensitized groups in our
study demonstrates its involvement in the sensitization
of food allergens.
Igj gene products are produced by antibody secreting
plasma cells after antigen or cytokine stimulation. They
are incorporated into pentameric IgM and dimeric IgA
immunoglobulins and play a crucial role in the cellular
and mucosal secretion of these molecules [43-45]. Pla-
ger et al. [43] reported that the expression of Igj is
down-regulated in patients with atopic dermatitis and
this may be due to isotype switching of plasma cells
from IgM and IgA production to IgG1 and IgE produc-
tion. Down-regulation of Igj in both microarray and
real-time RT-PCR experiments in our study among all
antigen sensitized treatments indicates a possible
Table 6 Plasma histamine concentrations in BALB/c mice after allergen treatment. BALB/c mice i.p. sensitized and
challenged with BLG, OVA and PNA had a rapid histamine induction 20 min after the challenge * p = 0.06; ** p < 0.01
Treatment Group Treatment Type Plasma Histamine Concentration (ng/ml) Plasma Histamine Level (LSM ± SEM)
PBS Sensitized and Challenged Control 24.12 2.96 ± 0.27
BLG Sensitized and Challenged Allergy 67.64 4.06 ± 0.27*
OVA Sensitized and Challenged Allergy 567.48 6.31 ± 0.27**
PNA Sensitized and Challenged Allergy 334.15 5.76 ± 0.27**
Table 7 Passive Cutaneous Anaphylaxis (PCA) assay in BALB/c mice. A blue wheal of a diameter of 3 mm or more, 30
min following challenge was considered as positive response and indicative of the presence of allergen-specific IgE
*p < 0.05
Treatment Diameter (mm) Positive Reaction
Groups Sensitization Allergen Challenge Mean ± SEM (n) Responder/Total
Naïve Serum PNA 0.9 ± 0.07 0/3
Naïve Control Naïve Serum OVA 0.8 ± 0.15 0/3
Naïve Serum BLG 1.0 ± 0.03 0/3
PBS SC Serum PNA 1.1 ± 0.13 0/3
PBS Control PBS SC Serum OVA 1.1 ± 0.21 0/3
PBS SC Serum BLG 1.4 ± 0.26 0/3
Experimental Group 1 PNA SC Serum PNA 5.1 ± 0.43* 4/4
Experimental Group 2 OVA SC Serum OVA 4.5 ± 0.74* 3/4
Experimental Group 3 BLG SC Serum BLG 4.1 ± 0.72* 3/4
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ported by the endpoints that we measured during the
challenge phase.
Several uniquely expressed genes were also activated
in response to BLG, OVA or PNA sensitization. For
example, Itgb1 was up-regulated by BLG sensitization;
this plasma membrane receptor is expressed on lympho-
cytes, monocytes and eosinophils, and may be involved
in inducing allergic inflammatory response [46,47].
Available reports also suggest that Itgb1 may be
involved in the airway smooth muscle responsiveness
through the association with fibronectin and type I col-
lagen during asthma or allergic inflammation [48]. The
observed up-regulation of Itgb1, as indicated by both
microarray analysis and real-time RT-PCR, is in agree-
ment with these available reports, and demonstrates its
possible role in food allergic process. In contrast, CD79a
was down-regulated in BLG sensitized group, and genes
Syt4 and Pex13 were up- and down-regulated, respec-
tively in OVA sensitized group. It is not known whether
the genes CD79a, Syt4 and Pex13 play any direct role in
any allergic conditions. However, microarray analysis
and real-time RT-PCR results from this study implicates
their involvement in BLG or OVA sensitization.
Gene ontology analysis was also used to reveal the biolo-
gical roles and molecular functions of the differentially
expressed genes that were commonly and uniquely
expressed among the allergen sensitized mice. These
enriched GO data further validated the involvement of the
differentially expressed genes in allergen sensitizations in
BALB/c mice. A total of 46 GO biological processes were
commonly enriched among all three antigen sensitized
groups (p ≤ 0.05) and at least 22 of these processes were
related to immune or hypersensitivity related processes
(Table 2). The most significant overlapping enriched GO
biological process was ther e s p o n s et os t i m u l u s
[GO:0050896]; this process was enriched with 50 genes
from the OVA and PNA sensitized groups, and with 100
genes from BLG sensitized group (Table 2). Within the
response to stimulus biological process, was a subcategory
biological process referred to as immune response
[GO:0006955]. A total of 30 genes from BLG, 12 genes
from OVA and 13 genes from PNA sensitized groups
enriched this biological process. In addition to the
immune response biological process other biological pro-
cesses that were subcategories within the response to sti-
mulus biological process were enriched with genes from
BLG, OVA and PNA sensitized groups. These subcate-
gories included the acute inflammatory response
[GO:0002526], humoral immune response [GO:0006959],
regulation of immunoglobulin mediated immune response
[GO:0002889] and regulation of B cell-mediated immunity
[GO:0002712]. Enrichment of these biological processes
indicates that the genes differentially expressed in
response to BLG, OVA or PNA sensitization are involved
in the process of immune regulation or hypersensitivity
responses.
Two common differentially expressed genes that were
involved in the enrichment of several of these immune
or hypersensitivity related biological processes were
Fcer1g and C3 (Table 3), whose expression was up-
regulated in all of the allergen treated groups of BALB/c
mice. Among other genes, Immunoglobulin heavy chain
complex (Igh-6), and Signal transducer and activator of
transcription 3 (Stat3), and Immunoglobulin joining
chain (Igj) also played important role in the enrichment
of other immune or hypersensitivity related biological
processes (Table 3). The involvement of FcεR1g,S t a t 3
and C3 with the allergic responses are very well docu-
mented. FcεR1g for example, is expressed on the surface
of mast cell and cross-linking of these IgE bound recep-
tors leads to mast cell degranulation, cytokine produc-
tion, prostaglandin synthesis, survival and passive
systemic anaphylaxis [49]. It has also been reported that
elevated level of transcription factor Stat3 is associated
with the induction of house dust mite-mediated allergic
inflammation and airway hyper-responsiveness in mice
[50]. Likewise, Stat3 is required for the active produc-
tion of IL-21-mediated IgE production by human B cells
[51]. Complement C3 plays a central role as a mediator
of airway hyper-responsiveness and asthma, and induces
the expression of the Th2 phenotype [52]. Anaphyla-
toxin C3a, an enzymatic derivative of C3 also acts as a
chemotactic factor that triggers the release of histamines
and cationic proteins from mast cells and eosinophils
respectively [53]. C3a also plays a role in smooth muscle
contraction that is mediated by leukotrienes, prosta-
noids, and platelet-activating factor released from mast
cells and eosinophils [53]. Other commonly enriched
GO biological processes include actin filament-based
process [GO:0030029] and muscle development process
[GO:0007517]. Enrichment of these two biological pro-
cesses suggests possible involvement of some of the dif-
ferentially expressed genes with smooth muscle
contraction, bronchoconstriction and vasodilation that
are the common phenomena associated with type I
allergic responses or anaphylaxis. Some of the differen-
tially expressed genes enriched these processes include
Scinderin (Scin), Supervillin (Svil) and Villin 1 (Vil1).
Scin is an actin-filament severing and capping protein
activated by calcium is known to be differentially
e x p r e s s e di nB A L B / cm i c ee x p o s e dt oO V A ,a n ds u g -
gested to be a potential biomarker of asthma, a type I
allergy [54]. Similarly, Vil1 is another actin-binding pro-
tein that is known for IgE-binding and IgE-cross-reactiv-
ity with other plant proteins of the same family [55].
Therefore, differential expression of these genes and
enrichment of these GO biological processes illustrate
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sensitizations.
GO analysis further revealed the molecular functions
of some of the differentially expressed genes (Table 4).
One significant overlapping enriched GO molecular
function was the calcium ion binding [GO: 0005509].
Enrichment of this molecular function is well correlated
with other enriched biological processes and emphasized
its involvement in the food allergy response. A recent
report suggests that the binding of the antigens with the
receptors on the T, B or mast cells induces a series of
biochemical reactions leading to a transient increase in
cytosolic free calcium concentration that leads to other
downstream reactions in the process of allergic response
[56]. Another report also suggests that antigen-induced
FcεRI-mediated cell migration/chemotaxis is dependent
on cytosolic free calcium concentration [57]. Therefore,
the enrichment of these GO biological processes and
molecular functions support the involvement of these
differentially expressed genes in the food allergic
responses during early sensitization phase. Thus, these
gene expression data enabled us to monitor the aller-
genicity of some of the common food allergens and
proved to be sensitive enough to identify the allergic/
immune responses within 24 h of the sensitizations in
the used animal model.
The experimental mice used in this study were sys-
temically exposed to the food antigens by i.p. injection
without any adjuvants, and they responded positively to
all of the antigens, as indicated by the increased ear
swelling response, elevated serum IgG1, IgE, plasma his-
tamine and a positive PCA test. Oral sensitization was
specifically avoided in this study because there is a
potential risk of developing oral tolerance when antigens
are administered via this route [25,29]. In order to avoid
the development of oral tolerance, adjuvants, such as
cholera toxin is being used during oral sensitization pro-
cesses. However, immune/allergic response developed
such a way does not mimic the actual immune/allergic
response in humans and this may lead to misinterpreta-
tion of the data due to hyperstimulation of the immune
system [26,27]. In our study, we sensitized the BALB/c
mice via the i.p. route with only two consecutive injec-
tions of allergens on day 0 and 1 without any adjuvants.
Use of this route for sensitization not only allowed us to
avoid the use of any kind of adjuvants but also allowed
us to observe the true effects of the allergens used with-
out having any unwanted external stimulations or influ-
ences. Thus, the gene expression data presented here in
our study corresponds only to the effects of the food
allergens used for sensitizations that may mimic the
actual allergic responses in humans. In this study, the
PCA data indicated that one mouse in BLG and another
mouse in the OVA treated group did not appear to be
sensitized. Although they were a different group of ani-
mals than those used for the gene expression study,
there is the possibility that non-responders may contri-
bute to the variation in gene expression during the sen-
sitization phase.
Conclusion
Taken together, microarray data from this study impli-
cate the involvement of many previously known genes
as well as numerous novel genes in the pathogenesis of
food allergy. This method of gene expression analysis
proved to be a sensitive method in identifying the aller-
genicity of known food proteins. Results from this study
will help to better understand the molecular mechanism
(s) involved in the sensitization to food allergens and
may help in developing new drug target for the therapy
of food allergy in future. The results presented here in
this study are only the first step and further studies are
needed to establish this method for using as a screening
tool to assess the allergenicity of other food proteins.
With further studies in future, the genes differentially
expressed here in this study may establish a pool of bio-
marker genes that can be used to determine the poten-
tial allergenicity of other food proteins of novel origin.
Future studies may want to consider characterizing the
effects of time and dose-response relationships among
these allergens and their influence on gene expression,
and investigate if this model is effective for identifying
allergens with low potency. Further studies are also
needed to observe the effects of a non-allergenic protein
on the gene expression profiling of this animal model.
Methods
Animals
S i x - t o - e i g h tw e e ko l df e m a l eB A L B / cm i c ew e r ep u r -
chased from Charles River (Saint-Constant, QC,
C a n a d a ) .A l lm i c ew e r em a i n t a i n e do nap e a n u t ,e g g
and milk free diet at the Charles River and University of
Guelph Central Animal facilities. Animals were main-
tained at 22-24°C at a relative humidity of 40-50%. The
light-to-dark cycle was maintained at 12 h from 7 AM
to 7 PM. All of the animal experiments were approved
by the University of Guelph Animal Care Committee
according the Canadian Council on Animal Care
(CCAC) guidelines.
Antigens (allergens) and reagents
Peanut agglutinin (PNA), ovalbumin (OVA) from hen’s
egg white, and b-lactoglobulin (BLG) from cow’sm i l k
were purchased from Sigma-Aldrich Canada (Oakville,
ON). The antigen concentrations used in this study
were primarily based on the previously published
reports [20,29,30] and our own pilot study (data not
reported).
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A group of female BALB/c mice (n = 24) were randomly
divided into four groups and each mouse received BLG,
OVA, PNA or PBS during sensitization. These mice were
sensitized over two consecutive days by a daily intraperi-
toneal (i.p.) injection of 250 μl of filter sterilized antigen
solution (2% BLG, 2% OVA or 0.2% PNA) in PBS or PBS.
Mice were euthanized 24 h after the second i.p. injection
using CO2 and MLNs were collected in cryogenic vials
then snap frozen immediately in liquid nitrogen. Samples
were stored at -70°C until total RNA was extracted.
Preparation of reference cDNA for microarray analysis
Naïve female BALB/c mice (n = 10) were considered a
common reference group for this study. Total RNA was
extracted from the MLNs of these naïve mice, pooled,
quantified and converted into cDNA as described below
for use as common reference cDNA for microarray
hybridization.
Total RNA extraction
Total RNA was extracted from the MLN of individual
mice using TRI Reagent (Ambion Inc., Austin, TX)
according to the manufacturer’s instruction. The
extracted total RNA was further purified using the QIA-
GEN RNeasy Mini Kit (QIAGEN Canada Inc., Missis-
sauga, ON) according to manufacturer’s instruction. The
quality and the concentration of the RNA samples were
determined with an Agilent 2100 Bioanalyzer (Agilent
Technologies, CA, USA) and a NanoDrop ND-1000
spectrophotometer (Thermo Fisher Scientific Inc., Wil-
mington, DE, USA).
Preparation, purification and labeling of cDNA
First strand cDNA was prepared, purified and labeled
using the SuperScript™ indirect cDNA labeling system
kit (Invitrogen, Canada) according to the manufacturer’s
instruction. Concentrations of the purified pre- and
post-labeled cDNA were determined with a NanoDrop®
ND-1000 spectrophotometer (Thermo Fisher Scientific
Inc., Wilmington, DE, USA). For each microarray hybri-
dization, equal amounts (~1 μg) of labeled common
reference cDNA and labeled sample cDNA from indivi-
dual mice sensitized with antigens (BLG, OVA or PNA)
or PBS were thoroughly mixed by pipetting and concen-
trated to a volume of 12 μlu s i n gas p e e d v a ca tah i g h
drying rate for 35-40 min. The final volume of the com-
bined cDNA sample was brought to 120 μl with Slide-
Hyb Hybridization Buffer # 1 (Ambion, TX, USA) and
mixed thoroughly by pipetting before hybridization.
Hybridization and scanning of the cDNA microarrays
Combined cDNA samples were hybridized to mouse 22.4
K cDNA arrays (University Health Network, Toronto,
ON, Canada) that contained 22.4 K clone sets of mouse
ESTs from the National Institute of Aging (NIA). For
each of the antigen (BLG, OVA or PNA) or PBS sensi-
tized groups, dye swapping was performed to minimize
dye bias. Hybridization and washing was conducted using
GeneTac HybStation (Genomic Solutions, MI, USA).
Hybridization was continued for 18 h at 42°C with mild
agitation. The arrays were washed with 3 different wash
solutions immediately after hybridization. Wash 1 was
carried out at 50°C with 5 cycles at a flowing time of 20 s
and a holding time of 40 s using wash solution 1 (1 ×
SSC, 0.1% SDS). Washes 2 and 3 were carried out with
wash solution 2 (0.1 × SSC, 0.1% SDS) and wash solution
3 (0.1 × SSC), respectively, at 40°C. The slides were
immediately removed from the HybStation after washing
and dried in a plastic tube by centrifugation at 400 × g
for 2 min. Microarray slides were scanned using Axon
4200A scanner (Molecular Devices, CA, USA) and the
images were recorded using GenePix Pro 6 software
(Molecular Devices, PA, USA). Microarray data files from
this study are available at EMBL-EBI ArrayExpress data-
base (http://www.ebi.ac.uk/microarray-as/ae/). ArrayEx-
press accession number for these files is E-MEXP-2676.
Analysis of microarray data
Microarray data was analyzed using GeneSpring GX 7.2
software (Agilent Technologies, CA, USA). Data were nor-
malized by per spot, per chip: intensity dependent LoW-
eSS (locally weighted scatterplot smoothing) method [58].
A gene was considered to be expressed, if it had an inten-
sity of >100. A gene was considered to be differentially
expressed and statistically significant, when it had a fold
change (expression ratio) of at least ± 1.5 with a p-value ≤
0.05. Benjamini and Hochberg multiple testing correction
was applied to minimize any false positive results. Gene
Ontology (GO) analysis was carried out using GoMiner
[59]. A GO biological process was considered to be
enriched when the Fisher’s exact p-value was ≤ 0.05.
Real-time RT-PCR
Total RNA was reverse-transcribed using SuperScript™
III Reverse Trancriptase kit (Invitrogen Canada) accord-
ing to manufacturer’s instruction. Concentrations of
cDNA were determined using Quant-iT™ PicoGreen®
dsDNA Kit (Molecular Probe, Invitrogen) according to
manufacturer’s instruction using a Victor 1420 Multila-
bel Counter machine (Perkin Elmer, MA, USA). Primers
(Table 8) for the genes for the real-time RT-PCR experi-
ment were generated using Primer Express software
(Applied Biosystems Inc., CA, USA). Before conducting
the real-time RT-PCR, regular PCR was performed on
each of the selected gene using Taq DNA Polymerase
(Invitrogen, Canada) on a GeneAmp PCR System 9700
machine (Applied Biosystems, CA, USA) to check the
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and primers to be used for real-time RT-PCR. Real-time
RT-PCR was conducted using the Platinum® SYBR®
Green qPCR SuperMix-UDG kit (Invitrogen Canada)
according to manufacturer’s instructions in an ABI
Prism 7000 Sequence Detection System machine
(Applied Biosystems Inc., CA, USA). The cDNA gener-
ated from common reference RNA samples from naïve
mice (same RNA source used for microarray experi-
ment) were used as negative control and RNA from the
PBS treated group of mice were used as positive control
in the real-time RT-PCR experiment. Standard curves
were prepared from serially diluted cDNAs prepared by
pooling cDNAs from all of the control and experimental
(BLG, OVA or PNA sensitized) cDNA samples. Data
generated from real-time RT-PCR were analyzed by
standard curve method for relative quantification of
gene expression [60]. All real-time RT-PCR data were
normalized relative to an internal control/housekeeping
gene (Ribosomal protein L13a; Rpl13a). A Student’s
t-test was performed to determine the statistical signifi-
cance of the analyzed genes and p-values of ≤ 0.05 were
considered to be statistically significant. A correlation
analysis between the real-time RT-PCR and microarray
fold changes of the validated genes was performed using
the Spearman’s rank correlation analysis. A Shapiro-
Wilk normality test for the fold change dataset was per-
formed prior to the correlation analysis.
Antigen sensitization and topical ear challenge
Another group of BALB/c mice (n = 48) were sensitized
similarly as described above. Mice were then topically
challenged 2 week post-sensitization on the dorsal side of
a tape-stripped ear with 5 μl of antigen solution (2% BLG,
2% OVA or 0.2% PNA) in PBS. The allergen challenge was
performed on the left ear while PBS was applied to the
right ear. Mice receiving BLG, OVA or PNA during sensi-
tization and challenge, as described above, were termed as
‘BLG SC’, ‘OVA SC’ or ‘PNA SC’, respectively. Another
group of mice that received PBS during sensitization and
challenge (PBS SC) was considered the negative control. A
third group of mice that received PBS during sensitization
and topical antigens during challenge was considered the
challenge control group (BLG C, OVA C, PNA C or PBS
C). Ear thickness was measured using a Quickmike digital
micrometer (Mitutoyo, Japan) at 0, 0.5, 1, 2, 6 and 24 h
post-challenge. The ear swelling response was determined
as the percent difference between test (antigen challenged)
and control (PBS challenged) ears [61].
Measurement of serum total IgG1 and IgE levels by ELISA
Mice were sensitized and challenged as described above
and then euthanized 24 h post challenge using CO2.
Blood was collected by cardiac puncture and centrifuged
at 20°C for 15 min at 700 × g to obtain serum. Serum
samples were stored at -70°C. Mouse IgG1 and IgE ELI-
SAs (Bethyl Laboratories Inc., Montgomery, TX) were
performed according to manufacturer’si n s t r u c t i o n s
with minor modifications. Serum samples were diluted
1:100,000 for IgG1 and 1:20 for IgE ELISA assays. Sup-
plied goat anti-mouse IgG1 (1:150,000) or IgE (1:20000)
HRP conjugates were diluted accordingly. The plates
were washed with the supplied wash buffer using a MW
96 microplate washer (Beckman Coulter, CA, USA).
The absorbance was read at 450 nm using a Victor 1420
Multilabel Counter machine (Perkin Elmer, MA, USA).
The concentrations of IgG1 and IgE immunoglobulins
in the samples were calculated by comparison with a
standard curve according to the manufacturer’si n s t r u c -
tions. All steps were performed at 20°C, unless other-
wise mentioned. IgG1 and IgE ELISA kits have a
detection limit of 250-3.9 ng/ml with inter- and intra-
assay coefficients of variation (CV) of 10%.
Measurement of plasma histamine levels
A third group of BALB/c mice (n = 24) were sensitized as
described above and challenged i.p. 2 week post-sensitization
Table 8 Primers for the real-time RT-PCR experiment.
Sequences of the forward and reverse primers of the
differentially expressed and housekeeping genes for the
real-time RT-PCR experiment
Accession
ID
Gene
Symbol
Direction Primer Sequence
House Keeping Gene
Mm.180458 Rpl13a Forward 5’
GAGAAACGGAAGGAAAAGGCC
Mm.180458 Rpl13a Reverse 5’ GCAGGCATGAGGCAAACAGT
Differentially Expressed Genes
Mm.127058 Stard4 Forward 5’ GAGTGGCGAGTTGCCAAAAA
Mm.127058 Stard4 Reverse 5’
CCACGTCATCCATAACTCCTTGA
Mm.1192 Igj Forward 5’ TCATCCCTTCCACCGAGGA
Mm.1192 Igj Reverse 5’ CCAGCTCCACTTCCACAGGA
Mm.8245 Timp1 Forward 5’ AAATGCCGCAGATATCCGGT
Mm.8245 Timp1 Reverse 5’
CTGATGTGCAAATTTCCGTTCC
Mm.1355 Cd79a Forward 5’ ACAGGCCAGCTGTTCTTCCC
Mm.1355 Cd79a Reverse 5’ GCTGTGATGATGCGGTTCTTG
Mm.263396 Itgb1 Forward 5’ CCAGTCCCAAGTGCCATGAG
Mm.263396 Itgb1 Reverse 5’
GCAGTAAGCGTCCATGTCTTCAC
Mm.286622 Pex13 Forward 5’ GTGGCCTGCCTTAGTGCTGA
Mm.286622 Pex13 Reverse 5’ CGTGGTCATCCTCACCACTTG
Mm.233846 Syt4 Forward 5’
CTTATCCCCACATCCAAGAGCTC
Mm.233846 Syt4 Reverse 5’ AGACCAGAAGTTCACCCCGG
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then euthanized 20 min post-challenge and heparinized
blood collected and centrifuged for 15 min at 20°C at 700 ×
g to obtain plasma. Samples were frozen at -70°C until ana-
lyzed. Plasma histamine concentrations were measured
using the ELISA kit manufactured by Labor Diagnostika
Nord GmbH & Co. (MEDICORP Inc., Montreal, QC) and
the concentration of histamine in the samples was calculated
by comparison with a standard curve according to the man-
ufacturer’s instructions. This ELISA kit has a detection limit
of 0.1-30 ng/ml with inter- and intra-assay CV of 12%.
Passive Cutaneous Anaphylaxis (PCA) assay
The PCA assay was conducted according to Dearman
and Kimber [20] and Li et al. [33] with minor modifica-
tions. The abdomen of each naïve mice was shaved and
then intra-dermally (i.d.) injected with 30 μlo fu n d i l u t e d
serum from an individual mouse that had been previously
sensitized and challenged with the antigens as described
above. Mice in the control group received the same
amount of undiluted serum from PBS SC or naïve mice.
After 48 h of serum sensitization, each mouse received
an intra-venous (i.v.) challenge of 100 μlo ft h er e l e v a n t
antigenic solution (2.5 μg/μl) combined with 0.5% Evans
blue dye in PBS. The appearance of a blue wheal at the
site of i.d. serum injection was observed within 30 min
following antigen challenge, and a reaction diameter of
3 mm or more was considered a positive PCA response.
Statistical analysis
Data from the ear swelling response, and IgG1 and IgE
ELISA experiments were statistically analyzed using SAS
s o f t w a r e( S A SI n s t i t u t eI n c . ,N C ,U S A ) .T h ed a t aw e r e
log transformed prior to analysis in order to stabilize
the variance. These experiments were designed as a ran-
domized complete block design. Experiments involving
the ear swelling response, and serum IgG1 and IgE
ELISA consisted of 4 blocks; 2 groups (SC and C) and 4
treatments (BLG, OVA, PNA and PBS) in a factorial
arrangement.
The mixed model method was used to analyze the
repeated ear swelling measurements over time according
to the method provided by Wang and Goonewardene
[62]. The best fitting variance structure over time for
antigen treatment and percent ear swelling was deter-
mined according to the Akaike criterion [62]. Linear
and quadratic orthogonal polynomial contrasts over
time and interactions of these with antigen treatments
and the PBS control were performed to compare the
time trends of ear swelling among the groups.
When analyzing the IgG1 and IgE ELISA data, Brown
and Forsythe’s [63] test was applied initially to compare
the variances among groups using a general linear model
(GLM) method. Mixed model methods were used for the
analysis, with separate variances fit for each of the 2
groups (SC and C) when necessary. Multiple comparisons
among the treatments within groups were performed and
Bonferroni’s correction was used to adjust the p-values to
control for the type-1 error rate. For the histamine ELISA
data, a mixed model procedure was used to determine the
least squares means (LSM) and a Dunnett’st e s tw a sp e r -
formed to compare the LSM of the allergen treated groups
to the PBS control group. A Student’s t-test was per-
formed to determine the statistical significance of the PCA
data. P-values less than or equal to 0.05 (p ≤ 0.05) were
considered to be statistically significant.
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